Literature DB >> 10522905

Interferon-beta1a in chronic inflammatory demyelinating polyneuropathy.

T Kuntzer1, A J Radziwill, R Lettry-Trouillat, C Naegeli, F Ochsner, B Erne, A J Steck, J Bogousslavsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10522905     DOI： 10.1212/wnl.53.6.1364

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  9 in total

Review 1.  Management of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard A C Hughes
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Treatment of refractory chronic inflammatory demyelinating polyneuropathy with interferon beta 1B.

Authors:  Eleonora Cocco; Elena Mamusa; Nicola Carboni; Giovanni Marrosu; Alessandro Vannelli; Maria Giuseppina Mascia; Antonella Sirca; Maria Giovanna Marrosu
Journal:  J Neurol       Date:  2005-06-20       Impact factor: 4.849

Review 3.  Chronic inflammatory demyelinating polyneuropathies: current treatment strategies.

Authors:  Thomas B Toothaker; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 4.  Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Mohamed Mahdi-Rogers; Ruth Brassington; Angela A Gunn; Pieter A van Doorn; Richard Ac Hughes
Journal:  Cochrane Database Syst Rev       Date:  2017-05-08

Review 5.  Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Krista Kuitwaard; Pieter A van Doorn
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

Review 6.  Status of immune mediators in painful neuropathies.

Authors:  Nurcan Uçeyler; Claudia Sommer
Journal:  Curr Pain Headache Rep       Date:  2008-06

7.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

Review 8.  Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.

Authors:  Amanda C Peltier; Peter D Donofrio
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

Review 9.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.